Related references
Note: Only part of the references are listed.The independent reduction inmortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction
Natasha K. Wolfe et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Ana Rakita et al.
SCIENTIFIC REPORTS (2020)
Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG) A Randomized, Double-Blind, Placebo-Controlled Trial (Publication with Expression of Concern. See vol. 143, 2021)
Laura M. Willemsen et al.
CIRCULATION (2020)
Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial
Alexander Kulik et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
Qian Ding et al.
NATURE COMMUNICATIONS (2019)
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis
Karla Solo et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
Hyoung Woo Chang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)
Marco Valgimigli et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Miguel Sousa-Uva et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting
Nayan Agarwal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis
Rhanderson Cardoso et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting A Randomized Clinical Trial
Qiang Zhao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial
Ali Hage et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
Perioperative aspirin and long-term survival in patients undergoing coronary artery bypass graft
Qian Ding et al.
SCIENTIFIC REPORTS (2018)
Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents
Adam Chakos et al.
ANNALS OF CARDIOTHORACIC SURGERY (2018)
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG FREEDOM Insights
Sean van Diepen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Quality of medical therapy in heart failure patients undergoing elective revascularisation: A protective effect of disease modifying therapy at discharge
Raphael Wurm et al.
SCIENTIFIC REPORTS (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Jonathan L. Halperin et al.
CIRCULATION (2016)
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The art of saphenous vein grafting and patency maintenance
Yaron Moshkovitz et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial
Harmen G. Booij et al.
CARDIOVASCULAR DRUGS AND THERAPY (2015)
Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up
Javaid Iqbal et al.
CIRCULATION (2015)
Novel RAAS agonists and antagonists: clinical applications and controversies
CesarA. Romero et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
Subodh Verma et al.
BMC SURGERY (2015)
Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery
Yiran Zhang et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)
Effect of Clopidogrel Use Post Coronary Artery Bypass Surgery on Graft Patency
Ramin Ebrahimi et al.
ANNALS OF THORACIC SURGERY (2014)
Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery Insights From PREVENT IV
Connie N. Hess et al.
CIRCULATION (2014)
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery
Miguel Sousa-Uva et al.
EUROPEAN HEART JOURNAL (2014)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
β-Blockers Improve Survival of Patients With Chronic Obstructive Pulmonary Disease After Coronary Artery Bypass Grafting
Emiliano Angeloni et al.
ANNALS OF THORACIC SURGERY (2013)
Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta-Analysis
Salil V. Deo et al.
JOURNAL OF CARDIAC SURGERY (2013)
Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting
Judson B. Williams et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial
Vasim Farooq et al.
EUROPEAN HEART JOURNAL (2012)
Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study
Vito Antonio Mannacio et al.
HEART (2012)
Mortality Benefit With Prasugrel in the TRITON-TIMI 38 Coronary Artery Bypass Grafting Cohort Risk-Adjusted Retrospective Data Analysis
Peter K. Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Trends in isolated coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons adult cardiac surgery database
Andrew W. ElBardissi et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery
Dimitri Kalavrouziotis et al.
AMERICAN HEART JOURNAL (2011)
Statin Therapy and Saphenous Vein Graft Disease After Coronary Bypass Surgery: Analysis From the CASCADE Randomized Trial
Alexander Kulik et al.
ANNALS OF THORACIC SURGERY (2011)
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
Claes Held et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Efficacy of Post-Operative Clopidogrel Treatment in Patients Revascularized With Coronary Artery Bypass Grafting After Myocardial Infarction
Rikke Sorensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Statins Decrease Adverse Outcomes in Coronary Artery Bypass for Extensive Coronary Artery Disease as well as Left Main Coronary Stenosis
Hui-Li Gan et al.
CARDIOVASCULAR THERAPEUTICS (2010)
Aspirin Plus Clopidogrel Therapy Increases Early Venous Graft Patency After Coronary Artery Bypass Surgery A Single-Center, Randomized, Controlled Trial
Ge Gao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effect of β-blocker use on outcomes after discharge in patients who underwent cardiac surgery
Anita Y. M. Chan et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Clopidogrel and Aspirin Versus Clopidogrel Alone on Graft Patency After Coronary Artery Bypass Grafting
Changqing Gao et al.
ANNALS OF THORACIC SURGERY (2009)
Statin Treatment Equalizes Long-Term Survival Between Patients With Single and Bilateral Internal Thoracic Artery Grafts
Michel Carrier et al.
ANNALS OF THORACIC SURGERY (2009)
Use of Aspirin Versus Clopidogrel Plus Aspirin After Coronary Artery Bypass Graft Surgery
Saurabh Sanon et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2009)
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
Patrick W. Serruys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Alexander Kulik et al.
CIRCULATION (2008)
Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery
Jean L. Rouleau et al.
CIRCULATION (2008)
Guideline on antiplatelet and anticoagulation management in cardiac surgery
Joel Dunning et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2008)
Effect of Angiotensin Converting Enzyme Inhibitors and β-Blockers on Left Ventricular Remodeling After Coronary Artery Bypass Graft Surgery
Yoshiaki Maruyama et al.
INTERNATIONAL HEART JOURNAL (2008)
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery
Sanjiv J. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery
Abhinav Goyal et al.
ANNALS OF THORACIC SURGERY (2007)
Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction
Purvi S. Gandhi et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2007)
Effect of pravastatin on progression of coronary atherosclerosis in patients after coronary artery bypass surgery - Pravastatin coronary artery bypass graft study
H Makuuchi et al.
CIRCULATION JOURNAL (2005)
Antiplatelet drugs
GJ Hankey et al.
MEDICAL JOURNAL OF AUSTRALIA (2003)
Aspirin and mortality from coronary bypass surgery
DT Mangano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Preoperative β-blocker use and mortality and morbidity following CABG surgery in North America
TB Ferguson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The Heart Outcomes Prevention Evaluation study: angiotensin-converting enzyme inhibitors: are their benefits a class effect or do individual agents differ?
DA Sica
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2001)
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS study)
M Oosterga et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Are β-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?
J Chen et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
